Skip to main content
Caplight Logo









Ynno Med

Ynno Med

Private
Hong KongHealthcare & Life Scienceshttps://www.ynnomed.com/

Last Round

Grant

Apr 1, 2025

Total Funding Raised

$1.13M

Company Overview

Ynno Med is a biotech company that has developed a drug R&D platform dedicated to addressing antimicrobial resistance by discovering and developing new antimicrobial agents.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryantimicrobial resistanceAMRnew antibioticsfirst-in-class drugsAI biotechdrug discoverypreclinical drug developmentin silico drug discoverycomputational drug discoverydrug R&D platformbacterial transcription inhibitorsdrug design servicesMRSAdrug candidate licensinggenerative chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ynno Med Comparables

Compare Ynno Med with similar companies based on industry and business-model similarity.

Ynno Med comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evolvere BioSciences
86%
Phare Bio
80%
Genesis Molecular AI
77%

Ynno Med Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2025
Corporate FundingOct 1, 2024
GrantApr 1, 2024
GrantApr 1, 2023
GrantApr 1, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2025

    $115K grant from Innovation and Technology Commission.

  • Oct 1, 2024

    Raised $192K in corporate funding.

Ynno Med Filings

Explore SEC and related filing metadata, where available.

Ynno Med filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ynno Med's valuation, stock price, and market status.

Is Ynno Med a public or private company?

Ynno Med is a private company.

What is the current stock price of Ynno Med?

Ynno Med is a private company with no public stock price. No recent secondary market data is available.

How much is Ynno Med worth (valuation)?

Valuation information for Ynno Med is not publicly available.

Can I buy Ynno Med stock?

Ynno Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ynno Med's last funding round?

Ynno Med's most recent funding round was Grant on April 1, 2025.

Who are the main investors in Ynno Med?

Key investors in Ynno Med include Hong Kong Science and Technology Park, Innovation and Technology Commission.

Will Ynno Med IPO soon?

No public IPO plans have been announced for Ynno Med.

How can I track Ynno Med secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ynno Med's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHong Kong
Employee Range1
Year Founded2021
Last FundingApr 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?